• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Vivos Therapeutics, Inc. - Common Stock (NQ:VVOS)

    0.7825 -0.0669 (-7.88%)
    Streaming Delayed Price Updated: 4:00 PM EDT, Apr 29, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 236,909
    Open 0.8600
    Bid (Size) 0.8000 (100)
    Ask (Size) 0.8480 (500)
    Prev. Close 0.8494
    Today's Range 0.7607 - 0.8606
    52wk Range 0.7607 - 7.950
    Shares Outstanding 8,988,106
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    New to The Street to Broadcast Tonight on Bloomberg at 6:30 PM EST - Show #744 Featuring Virtuix Holdings (NASDAQ:VTIX), Neonc Technologies Holdings (NASDAQ:NTHI), Medicus Pharma (NASDAQ:MDCX), YY Group Holding (NASDAQ:YYGH), and Vivos Therapeutics
    Via ACCESS Newswire
    Thursday's session: gap up and gap down stocks ↗
    Via Chartmill

    Performance

    YTD
    -69.1%
    -69.1%
    1 Month
    -28.2%
    -28.2%
    3 Month
    -54.2%
    -54.2%
    6 Month
    -70.7%
    -70.7%
    1 Year
    -70.4%
    -70.4%

    More News

    Read More
    What's going on in today's pre-market session ↗
    Via Chartmill
    News headline image
    New to The Street to Broadcast on Fox Business on Monday, April 13, Featuring Virtuix Holdings (NASDAQ:VTIX), Medicus Pharma (NASDAQ:MDCX), YY Group Holdings (NASDAQ:YYGH), Vivos Therapeutics (NASDAQ:VVOS), and Stardust Power (NASDAQ:SDST)
    Via ACCESS Newswire
    News headline image
    Earnings Outlook For Vivos Therapeutics ↗
    Via Benzinga
    Curious about the stocks that are showing activity after the closing bell on Friday? ↗
    Via Chartmill
    News headline image
    New to The Street Broadcasts Show #740 on Bloomberg Television at 6:30 PM EST Featuring Medicus (MDCX), Acme Markets- Canton Foundation, Alpha Ton Capital (ATON), and Virtuix Holdings (NASDAQ:VTIX)
    Via ACCESS Newswire
    News headline image
    New to The Street to Broadcast Executive Leadership Interviews Featuring Medicus Pharma Ltd. (NASDAQ:MDCX), CitroTech (NYSE:CITR), Vivos Therapeutics, Inc. (NASDAQ:VVOS), and Virtuix Holdings ($VTIX) on Bloomberg Television Tonight at 6:30 PM EST
    Via ACCESS Newswire
    News headline image
    New to The Street to Broadcast Executive Leadership Interviews Tonight at 6:30 PM EST on Bloomberg Television Across the U.S., MENA and Latin America
    Via ACCESS Newswire
    News headline image
    New to The Street to Broadcast Show #726 on Bloomberg at 6:30 PM EST Featuring Vivos Therapeutics (NASDAQ:VVOS), Aeries Technology (NASDAQ:AERT), Virtuix Holdings (NASDAQ:VTIX), and Stardust Power (NASDAQ:SDST)
    Via ACCESS Newswire
    News headline image
    VIVOS Therapeutics, Inc. ($VVOS) Signs 12-Part Media Series with New to The Street
    Via ACCESS Newswire
    News headline image
    This Alto Neuroscience Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday ↗
    Via Benzinga
    News headline image
    12 Health Care Stocks Moving In Friday's After-Market Session ↗
    Via Benzinga
    News headline image
    Vivos Reports 7% Sales Drop ↗
    Via The Motley Fool
    News headline image
    Vivos Therapeutics Unveils New Model ↗
    Via The Motley Fool
    News headline image
    These stocks are moving in today's session ↗
    Via Chartmill
    News headline image
    Unusual volume stocks in Wednesday's session ↗
    Via Chartmill
    News headline image
    12 Health Care Stocks Moving In Tuesday's Intraday Session ↗
    Via Benzinga
    News headline image
    Which stocks are experiencing notable movement on Tuesday? ↗
    Via Chartmill
    News headline image
    Let's uncover which stocks are experiencing notable gaps during today's session. ↗
    Via Chartmill
    News headline image
    Gapping stocks in Thursday's session ↗
    Via Chartmill
    News headline image
    12 Health Care Stocks Moving In Friday's Pre-Market Session ↗
    Via Benzinga
    Water Tower Research Publishes Initiation of Coverage Report on Vivos Therapeutics, Inc., “New Strategic Model & Key Regulatory Milestones Provide Revenue Tailwind”
    Via TheNewswire.com
    News headline image
    Earnings Scheduled For May 15, 2025 ↗
    Via Benzinga
    News headline image
    Earnings Scheduled For March 31, 2025 ↗
    Via Benzinga

    Frequently Asked Questions

    Is Vivos Therapeutics, Inc. - Common Stock publicly traded?
    Yes, Vivos Therapeutics, Inc. - Common Stock is publicly traded.
    What exchange does Vivos Therapeutics, Inc. - Common Stock trade on?
    Vivos Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Vivos Therapeutics, Inc. - Common Stock?
    The ticker symbol for Vivos Therapeutics, Inc. - Common Stock is VVOS on the Nasdaq Stock Market
    What is the current price of Vivos Therapeutics, Inc. - Common Stock?
    The current price of Vivos Therapeutics, Inc. - Common Stock is 0.7825
    When was Vivos Therapeutics, Inc. - Common Stock last traded?
    The last trade of Vivos Therapeutics, Inc. - Common Stock was at 04/29/26 04:00 PM ET
    What is the market capitalization of Vivos Therapeutics, Inc. - Common Stock?
    The market capitalization of Vivos Therapeutics, Inc. - Common Stock is 7.03M
    How many shares of Vivos Therapeutics, Inc. - Common Stock are outstanding?
    Vivos Therapeutics, Inc. - Common Stock has 7M shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.